Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Missense3D-PPI: A Web Resource to Predict the Impact of Missense Variants at Protein Interfaces Using 3D Structural Data. | J Mol Biol | 2023 | 37356905 | PubTator, text mining | PubMed |
| SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS. | Biochim Biophys Acta Mol Cell Biol Lipids | 2023 | 37348646 | PubTator, text mining | PubMed |
| Oxalate as a potent promoter of kidney stone formation. | Front Med (Lausanne) | 2023 | 37342493 | PubTator, text mining | PubMed |
| Effects of interleukin-23 on the activation of mucosal-associated invariant T cells from oral lichen planus. | J Int Med Res | 2023 | 37340721 | PubTator, text mining | PubMed |
| Signaling metabolite β-aminoisobutyric acid as a metabolic regulator, biomarker, and potential exercise pill. | Front Endocrinol (Lausanne) | 2023 | 37313446 | PubTator, text mining | PubMed |
| Heterogeneity in biomarkers, mitogenome and genetic disorders of the Arab population with special emphasis on large-scale whole-exome sequencing. | Arch Med Sci | 2023 | 37313193 | PubTator, text mining | PubMed |
| Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis. | Nat Commun | 2023 | 37308477 | PubTator, text mining | PubMed |
| Identification of mutations in 15 nephrolithiasis-related genes leading to a molecular diagnosis in 85 Chinese pediatric patients. | Pediatr Nephrol | 2023 | 37306718 | PubTator, text mining | PubMed |
| E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting "E2F2/miR-16-5p/SPTLC1" schema. | Transl Oncol | 2023 | 37300925 | PubTator, text mining | PubMed |
| Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients. | Int J Mol Sci | 2023 | 37298446 | PubTator, text mining | PubMed |
| Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. | Signal Transduct Target Ther | 2023 | 37286535 | PubTator, text mining | PubMed |
| Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus. | J Biol Chem | 2023 | 37286040 | PubTator, text mining | PubMed |
| Research progress on renal calculus associate with inborn error of metabolism. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37283101 | PubTator, text mining | PubMed |
| Leader peptide or pro-segment mutants of renin are misrouted to mitochondria in autosomal dominant tubulointerstitial kidney disease. | Dis Model Mech | 2023 | 37283036 | PubTator, text mining | PubMed |
| Genomic diversity and ecological distribution of marine Pseudoalteromonas phages. | Mar Life Sci Technol | 2023 | 37275543 | PubTator, text mining | PubMed |
| Delta weight loss unlike genetic variation associates with hyperoxaluria after malabsorptive bariatric surgery. | Sci Rep | 2023 | 37270618 | PubTator, text mining | PubMed |
| Accelerated Chemical Reaction Optimization Using Multi-Task Learning. | ACS Cent Sci | 2023 | 37252348 | PubTator, text mining | PubMed |
| Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. | Front Neurosci | 2023 | 37250416 | PubTator, text mining | PubMed |
| The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends. | Arch Toxicol | 2023 | 37248308 | PubTator, text mining | PubMed |
| β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects. | Adv Nutr | 2023 | 37247842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=21